MediWound Ltd (NAS:MDWD)
$ 17.7 -0.13 (-0.73%) Market Cap: 190.98 Mil Enterprise Value: 153.28 Mil PE Ratio: 0 PB Ratio: 5.58 GF Score: 56/100

Q2 2019 Mediwound Ltd Earnings Call Transcript

Aug 13, 2019 / 12:30PM GMT
Release Date Price: $22.19 (-3.21%)
Operator

Good day, ladies and gentlemen, and welcome to the Second Quarter MediWound 2019 Conference Call. (Operator Instructions) As a remainder, this conference is being recorded.

I would now like to introduce your host for today's conference. Ms. Monique Kosse. You may begin.

Monique Kosse
LifeSci Advisors, LLC - MD

Thank you, Catherine, and good morning, everyone. Earlier today, MediWound issued a press release announcing its financial results and provided a business update for the second quarter of 2019. You may access that release on the website under the Investors tab.

With us today are Sharon Malka, Chief Executive Officer of MediWound; and Boaz Gur-Lavie, Chief Financial Officer of MediWound. Following management's prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session relating to MediWound's expected future performance, future business prospects or future events or plans are forward-looking statements as defined

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot